CHRISTINE HAGGERTY: Open Payments
NPI 1457649089 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 47 payments from 11 companies in 2025. Trend: 2023 $1,378 · 2024 $1,022 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $271 |
| Janssen Biotech, Inc. | 4 | $226 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $108 |
| Lilly USA, LLC | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 5 | $50 |
| QOL Medical, LLC | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Boston Scientific Corporation | 1 | $16 |
Products named: TREMFYA, LINZESS, OMVOH, SKYRIZI, RINVOQ, ENTYVIO, XIFAXAN, VOQUEZNA.
Industry payments across OH — which companies pay providers there.
